Wellington Management Group LLP 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-04 09:17 am Sale |
2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Wellington Management Group LLP | 1,763,053 3.420% |
-1,141,669![]() (-39.30%) |
Filing |
2021-02-03 3:11 pm Purchase |
2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Wellington Management Group LLP | 2,904,722 6.390% |
2,904,722![]() (New Position) |
Filing |